All stock lists
Fidelity National Financial, Inc. (New York Stock Exchange:FNF)
US · Delayed Price · Currency is USD
Financial Services · Insurance - Specialty
44.72-0.32 (-0.71%)
Market cap
$12.0B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 14, 2005
Website
Insider Score
––Not scored
FNF Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
FNF analyst forecast
FNF analyst consensus
Moderate Buy3 ratings
Buy 2 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
FNF 12-month price target
$54.50+21.9% upsideaverage of 2 firms
$59.00High
$50.00Low
FNF ratings mix, last 12 months
Buy Hold Sell
Best analysts covering FNF
- Truist Securities100%success rate · +26.2% avg return · 8 calls
- Stephens & Co.80%success rate · +24.4% avg return · 10 calls
- Keefe, Bruyette & Woods50%success rate · +13.7% avg return · 4 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
FNF analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-11-09 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-10-21 |
| Stephens | — | $50.00 | +23.5% | — | 2026-10-21 | |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-10-15 |
| Truist Financial | — | $59.00 | +50.3% | — | 2026-10-15 | |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-10-05 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-08-24 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-08-10 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-08-07 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-07-07 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-06-25 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2026-05-12 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-05-11 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-04-10 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-04-06 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2026-02-23 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-01-06 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2025-12-18 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2025-11-10 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-10-06 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-07-08 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Upgraded | 2025-04-08 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-02-24 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-02-24 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2025-01-08 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2025-01-06 |
| — | Deutsche Bank | Buy | — | — | Upgraded | 2025-01-03 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-12-10 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-11-11 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-11-08 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-10-08 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-09-04 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-08-15 |
| — | Deutsche Bank | Hold | — | — | Reiterated | 2024-08-07 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-08-07 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-08-07 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-08-06 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-08-06 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-07-02 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-05-13 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-05-10 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-04-09 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-03-21 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2024-02-26 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2024-02-23 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-02-23 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Reiterated | 2023-12-13 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-11-14 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-11-09 |
| — | Keefe, Bruyette & Woods | Market Perform | — | — | Downgraded | 2023-10-02 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-08-17 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-08-10 |
| — | BTIG | Buy | — | — | Reiterated | 2023-08-10 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-08-09 |
| — | Keefe, Bruyette & Woods | Outperform | — | — | Reiterated | 2023-05-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2023-05-05 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-05-05 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-05-04 |
| — | Barclays | Overweight | — | — | Reiterated | 2023-04-13 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-03-02 |
FNF earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-19 | 1.51 | 1.41 | $3.66B | $4.05B |
| 2026-05-06 | 1.09 | 0.93 | $3.61B | $3.23B |
| 2026-08-05 | 1.31 | 1.39 | $3.79B | $4.05B |
| 2026-11-05 | 1.32 | 1.32 | $3.78B | $3.58B |
| 2027-02-18Upcoming | 1.28 | — | $3.68B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.